Brief: Akoustis Technologies Inc On Oct 10, Co Received Notice From Nasdaq That It Is Not In Compliance With Nasdaq Listing Rule 5550(B)(1)
11/10/2024 23:02
Akoustis Technologies Inc AKTS.O :
* AKOUSTIS TECHNOLOGIES INC: ON OCT 10, CO RECEIVED NOTICE
FROM
NASDAQ THAT IT IS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE
5550(B)(1)
Source text for Eikon: ID:n0001213900-24-087313
Further company coverage: AKTS.O
Recent news on Aktis Oncology
See all newsAktis Oncology Q2 net loss widens on higher R&D, administrative costs
U.S. RESEARCH ROUNDUP-Danaher, GM, MSCI
Aktis Oncology Q1 net loss widens on increased IPO-related expenses
Generate Biomedicines shares fall 6% in weak Nasdaq debut for drug developer (updated)
Flagship-backed Generate Biomedicines shares fall 6% in Nasdaq debut